Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


25.06.2018

1 Am J Dermatopathol
1 Anticancer Res
3 Clin Cancer Res
1 Int J Cancer
3 J Am Acad Dermatol
2 Lancet Oncol
1 Melanoma Res
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. WOODBECK R, Metelitsa AI, Naert KA
    Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma.
    Am J Dermatopathol. 2018;40:523-526.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. ASANO M, Matsui J, Towle MJ, Wu J, et al
    Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven(R)): Combination with Anticancer Agents of Differing Mechanisms.
    Anticancer Res. 2018;38:3375-3385.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  3. WARNER AB, Postow MA
    Bigger is not always better: Tumor size and prognosis in advanced melanoma.
    Clin Cancer Res. 2018 Jun 14. pii: 1078-0432.CCR-18-1311.
    PubMed     Text format     Abstract available

  4. PAWELEC G
    Unexpected benefits of aging for favorable responses to PD-1 blockade in melanoma?
    Clin Cancer Res. 2018 Jun 15. pii: 1078-0432.CCR-18-1475.
    PubMed     Text format     Abstract available

  5. DANKNER M, Lajoie M, Moldoveanu D, Nguyen TT, et al
    Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanoma.
    Clin Cancer Res. 2018 Jun 14. pii: 1078-0432.CCR-17-3384.
    PubMed     Text format     Abstract available


    Int J Cancer

  6. HUSER L, Sachindra, Granados K, Federico A, et al
    SOX2-mediated upregulation of CD24 promotes adaptive resistance towards targeted therapy in melanoma.
    Int J Cancer. 2018 Jun 15. doi: 10.1002/ijc.31609.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  7. ROSENBERG AR, Weston SJ, Deshields T, Fields RC, et al
    Health-related quality of life in patients with malignant melanoma by stage and treatment status.
    J Am Acad Dermatol. 2018 Jun 12. pii: S0190-9622(18)32068.
    PubMed     Text format    

  8. MUN JH, Jo G, Darmawan CC, Park J, et al
    Association between Breslow Thickness and Dermoscopic Findings in Acral Melanoma.
    J Am Acad Dermatol. 2018 Jun 12. pii: S0190-9622(18)32065.
    PubMed     Text format     Abstract available

  9. KWON GP, Gamba CS, Stefanick ML, Swetter SM, et al
    Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.
    J Am Acad Dermatol. 2018;79:145-147.
    PubMed     Text format    


    Lancet Oncol

  10. DRENO B, Thompson JF, Smithers BM, Santinami M, et al
    MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Lancet Oncol. 2018 Jun 13. pii: S1470-2045(18)30254.
    PubMed     Text format     Abstract available

  11. DAUD AI
    Negative but not futile: MAGE-A3 immunotherapeutic for melanoma.
    Lancet Oncol. 2018 Jun 13. pii: S1470-2045(18)30353.
    PubMed     Text format    


    Melanoma Res

  12. MONTAUDIE H, Picard A, Panaia-Ferrari P, Boukari F, et al
    Painful acute thyroiditis following a first cure of Ipilimumab plus Nivolumab for metastatic melanoma.
    Melanoma Res. 2018;28:368-369.
    PubMed     Text format    


    PLoS One

  13. KEELEY T, Lin S, Lester DK, Lau EK, et al
    The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells.
    PLoS One. 2018;13:e0199128.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: